Yoichiro Nishida
Overview
Explore the profile of Yoichiro Nishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, et al.
J Neuroimaging
. 2024 Oct;
34(6):758-765.
PMID: 39390692
Background And Purpose: Slowly expanding lesions (SELs) have been proposed as novel MRI markers of chronic active lesions in multiple sclerosis (MS). However, the mechanism through which SELs affect brain...
2.
Takahashi S, Ono D, Shintaku H, Oyama J, Nishida Y, Ishikawa K, et al.
Intern Med
. 2024 Sep;
PMID: 39343569
We present a 76-year-old man with cryptogenic new-onset refractory status epilepticus (C-NORSE) with an initial abnormal signal in the nucleus accumbens and a remarkable hyperintense signal on T1-weighted magnetic resonance...
3.
Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, et al.
J Neuroimmunol
. 2024 Jul;
394:578407.
PMID: 39068747
Progression independent of relapse activity (PIRA) is prevalent among Caucasian patients with relapsing and remitting multiple sclerosis (RRMS). However, there is limited knowledge regarding the characteristics of PIRA in Asian...
4.
Kuwabara S, Kusunoki S, Kuwahara M, Yamano Y, Nishida Y, Ishida H, et al.
J Peripher Nerv Syst
. 2024 Jul;
29(3):339-349.
PMID: 38987228
Background And Aims: Guillain-Barré syndrome (GBS) is an acute, self-limited, immune-mediated peripheral neuropathy. Current treatments for GBS include intravenous immunoglobulin (IVIg) and plasma exchange, which may not sufficiently benefit severely...
5.
Okamoto T, Ishizuka T, Shimizu R, Asahina Y, Nakamura H, Shimizu Y, et al.
JMIR Res Protoc
. 2024 Jan;
13:e46709.
PMID: 38224478
Background: Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system that causes myelin sheath damage and axonal degeneration. The glycolipid (2S, 3S, 4R)-1-O-(α-d-galactosyl)-2-tetracosanoylamino-1,3,4-nonaetriol (OCH-NCNP1 or OCH)...
6.
Yokote H, Miyazaki Y, Toru S, Nishida Y, Hattori T, Niino M, et al.
Mult Scler Relat Disord
. 2022 Aug;
67:104077.
PMID: 35926261
Background: Different treatment strategies can have varying effects on disability and whole brain volume in patients with multiple sclerosis (MS). However, the association between regional brain volume and treatment efficacy...
7.
Yamada A, Nishida Y, Wake K, Nakamura A, Sakamaki Y, Kuwahara H, et al.
Microscopy (Oxf)
. 2022 Feb;
71(2):124-131.
PMID: 35157050
Precise immunolocalization of molecules in relation to ultrastructural features is challenging, especially when the target is small and not frequent enough to be included in tiny ultrathin sections randomly selected...
8.
Nishida Y, Ishiguro T, Yokota T
JAMA Neurol
. 2021 Nov;
79(2):194.
PMID: 34807237
No abstract available.
9.
10.
Shinya A, Takahashi M, Sato N, Nishida Y, Inaba A, Inaji M, et al.
Intern Med
. 2021 Feb;
60(14):2301-2305.
PMID: 33612672
A 42-year-old man with a history of migraine and bilateral syndactyly presented with numbness of the extremities and shaking legs, which thus prevented him from working as a carpenter. A...